Theranos still hasn’t provided the one thing that could reassure doubters for goodByMax NisenMax Nisen
Eric Schmidt explains how Alphabet will emulate Berkshire Hathaway and Warren BuffettByMax NisenMax Nisen
Panicking journalists allegedly trespassing at the Gigafactory ran over two Tesla employees in a JeepByMax NisenMax Nisen
It’s hard to fire people who work remotely, as one unfortunate Twitter employee just discoveredByMax NisenMax Nisen
Craft coffee darling Stumptown was just bought by Peet’s and its secretive German ownersByMax NisenMax Nisen
Canada is trying to cut the price of a $525,000-a-year drug, and is getting sued for itByMax NisenMax Nisen
Volkswagen’s ex-CEO is being investigated for fraud amid the automaker’s huge emissions scandalByMax NisenMax Nisen
It appears Porsche’s leader now has the very tough task of halting Volkswagen’s free fallByMax NisenMax Nisen
There’s one particular company that would really hate Hillary Clinton’s drug price planByMax NisenMax Nisen
